TD Private Client Wealth’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.12M | Sell |
5,098
-92
| -2% | -$20.1K | 0.03% | 335 |
|
2025
Q1 | $1.16M | Buy |
5,190
+648
| +14% | +$145K | 0.03% | 316 |
|
2024
Q4 | $1.49M | Buy |
4,542
+305
| +7% | +$99.9K | 0.04% | 281 |
|
2024
Q3 | $1.27M | Sell |
4,237
-137
| -3% | -$41.1K | 0.04% | 329 |
|
2024
Q2 | $1.44M | Buy |
4,374
+790
| +22% | +$260K | 0.05% | 295 |
|
2024
Q1 | $1.42M | Sell |
3,584
-64
| -2% | -$25.3K | 0.05% | 297 |
|
2023
Q4 | $1.28M | Sell |
3,648
-40
| -1% | -$14.1K | 0.05% | 300 |
|
2023
Q3 | $1.38M | Sell |
3,688
-202
| -5% | -$75.8K | 0.06% | 269 |
|
2023
Q2 | $1.49M | Sell |
3,890
-235
| -6% | -$89.9K | 0.06% | 269 |
|
2023
Q1 | $1.43M | Sell |
4,125
-46
| -1% | -$15.9K | 0.06% | 272 |
|
2022
Q4 | $982K | Buy |
4,171
+118
| +3% | +$27.8K | 0.05% | 326 |
|
2022
Q3 | $997K | Sell |
4,053
-120
| -3% | -$29.5K | 0.05% | 311 |
|
2022
Q2 | $1.26M | Sell |
4,173
-643
| -13% | -$194K | 0.06% | 283 |
|
2022
Q1 | $1.98M | Sell |
4,816
-328
| -6% | -$135K | 0.08% | 238 |
|
2021
Q4 | $2.41M | Buy |
5,144
+295
| +6% | +$138K | 0.1% | 206 |
|
2021
Q3 | $2.06M | Sell |
4,849
-575
| -11% | -$244K | 0.09% | 228 |
|
2021
Q2 | $1.95M | Sell |
5,424
-385
| -7% | -$138K | 0.08% | 241 |
|
2021
Q1 | $1.64M | Buy |
5,809
+484
| +9% | +$136K | 0.08% | 259 |
|
2020
Q4 | $1.51M | Buy |
5,325
+280
| +6% | +$79.3K | 0.08% | 255 |
|
2020
Q3 | $1.39M | Buy |
5,045
+604
| +14% | +$166K | 0.08% | 247 |
|
2020
Q2 | $1.01M | Buy |
4,441
+1,465
| +49% | +$333K | 0.06% | 279 |
|
2020
Q1 | $453K | Buy |
2,976
+202
| +7% | +$30.8K | 0.03% | 333 |
|
2019
Q4 | $417K | Buy |
+2,774
| New | +$417K | 0.03% | 373 |
|